Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4566_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
21 Мб
Скачать
Methods of dierent sleep tests
EOG
EOG
https://t.me/medicina_free
EOG
EEG
EEG
EMG
Figure 4. Stage N2 sleep (NREM 2). Reproduced and modified from Riha (2012) with permission.
EOG
EEG
EEG
Spindle K complex
waves
EMG
Figure 5. Stage N3 sleep (NREM 3). Note slow, high-amplitude δ-waves. Reproduced and modified from Riha (2012) with permission.
Respiratory event scoring
Although scoring sleep using the EEG, EOG and mentalis/submentalis EMG has been standardised since 1968 and more recently since 2007 (with multiple iterations in the past 15 years), attempts to standardise the scoring of respiratory events were made in 1999 and again in 2007. The reader is referred to the most recent version of
124
ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
EOG
ECG
https://t.me/medicina_free
EOG
REMs
EEG
EEG
EMG
Sawtooth waves
Phasic twitch
Figure 6. Stage R (REM). Reproduced and modified from Riha (2012) with permission.
2.5 mV
EMG
31.3 µV
EOG(L) 250 µV
EOG(R) 250 µV
EEG
250 µV
100
SpO
2
50
THOR RES
×1
ABDO RES
×1
Nasal
airflow
×1
Airflow
×1
EMGdia-
phragm
62.5 µV SOUND
×1
LEG(L) 20 mV
LEG(R) 20 mV
F
POSITION
B L R
Figure 7. 5-min page of PSG showing obstructive respiratory events (ObA) accompanied by desaturations and arousals. THOR RES: thoracic respiratory band; ABDO RES: abdominal respiratory band; F: front; B: back; L: le side; R: right side. Reproduced and modified from Riha (2012) with permission.
the AASM manual for the latest scoring guidelines for respiratory events. Figures 7–9 summarise commonly recorded respiratory events.
With respect to sleep apnoea, severity is still classified according to AHI, at time of publication. AHI is defined as the total number of apnoeas and hypopnoeas scored during sleep, divided by the total sleep time in hours as recorded using the EEG. This term should only be used when a PSG has been performed, not any other test.
125ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
ECG
ECG
https://t.me/medicina_free
2.5 mV EMG
15.6 µV EOG(R)
250 µV
EOG(L)
250 µV
EEG
250 µV
100
PtcCO
2
mmHg
50
100
SpO
2
50
THOR RES
×1
ABDO RES
×1
Nasal
pressure
×1
Airflow
×1
EMGdia-
phragm
31.3 µV SOUND
×1
LEG(L)
20 mV
LEG(R)
F
20 mV
B
L
POSITION
R
Figure 8. 5-min page of PSG showing hypopnoeas (Hyp) accompanied by desaturations on the oxygen saturation trace. THOR RES: thoracic respiratory band; ABDO RES: abdominal respiratory band; F: front; B: back; L: le side; R: right side. Reproduced and modified from Riha (2012) with permission.
2.5 mV
EMG
15.6 µV EOG(R)
250 µV
EOG(L)
250 µV
EEG
250 µV
100
SpO
2
THOR RES
×1
ABDO RES
×1
Nasal
pressure
×1
Airflow
×1
EMGdia-
phragm
62.5 µV
SOUND
×1
LEG(L)
20 mV LEG(R)
20 mV
POSITION
50
F B
L
R
Figure 9. 10-min page of PSG showing central apnoeas showing a CSR pattern. THOR RES: thoracic respiratory band; ABDO RES: abdominal respiratory band; F: front; B: back; L: le side; R: right side. Reproduced and modified from Riha (2012) with permission.
126
ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
https://t.me/medicina_free
Although work is being carried out to determine whether AHI is still the most suitable ‘metric’ to classify the severity of SDB, at time of publication, it continues to be classified as severe if the AHI is >30 events·h−1 of sleep, moderate if the AHI is 15–30 events·h−1 of sleep and mild if the AHI is <15 and >5 events·h−1 of sleep. What is important to bear in mind is that sleep eciency (the time actually slept as scored on the EEG divided by the time in bed) can impact the AHI, raising it significantly if low and diluting it if high. Additionally, little heed is currently paid to the fact that age and sex can influence what might be considered normal values within the general population with little impact discernible on generating symptoms of sleep apnoea syndrome.
Scoring and reporting parasomnias and abnormal movements during sleep
There are a large variety of phenomena that occur during sleep ranging from what might be considered normal (e.g. hypnic myoclonus, periodic limb movements), to what might be considered abnormal and potentially harmful to the individual and/or a co-sleeper (e.g. violent dream-enactment behaviour, sleep-walking). These activities during sleep are described in the ICSD-3 classification (2014) under headings 5 and 6. They may or may not impact on SDB and vice versa. Video-PSG can be vital to the diagnosis of such disorders and provide clarification as to the sleep stage during which they occur. Additional EMG montage is also contributory.
The reader is referred to the latest AASM scoring guideline and to the ICSD-3 for an exhaustive guide on scoring and classification.
ECG evaluation
The ECG captured during PSG is generally in the form of a single rhythm trace. ECG lead II is most frequently used with torso placement. However, depending on the study, this can be modified. In adults, sinus tachycardia is defined as >90 beats per min and bradycardia as <40 beats per min. Important information must not be overlooked in respect of morphology, rhythm and rate captured as many cardiac abnormalities can be silent and only picked up when sleep monitoring is performed.
The reader is referred to Hampton et al. (2019) for a detailed summary of normal and abnormal ECG traces and the latest AASM guideline on cardiac rules during sleep.
Video monitoring during PSG
Using video to monitor the sleep period is almost universally implemented. First, video monitoring provides protection for the patient and the sta during a potentially vulnerable situation for both. The video is also used to capture any behaviour witnessed during the PSG study, be it during wakefulness or during sleep. It is indispensable in the case of diagnosing abnormal movements during sleep, parasomnias and epilepsy.
Summary and interpretation of the PSG
Once scored, the consolidated output of the PSG is formatted and reported in a standardised fashion, containing the most important information and observations from the sleep period. Generally, the hypnogram is displayed, along with respiratory events, body position, oxygen trace (with/without transcutaneous CO2 trace), sound if obtained, leg movements, ECG and arousals in addition to a video report, a narrative about any events occurring during the testing period and sleep period, and a table summarising important numerical observations such as sleep onset latency, percentages of dierent sleep stages, nadir oxygen saturation measured by pulse oximetry (S
), AHI, etc.
pO
2
127ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
Cn.A
RERA
Uns
Mx.H
Ob.H
Cn.H
Mx.A
Ob.A
Time Hours Epoch
Arousal graph
Sleep stage summary
Apnoea graph
Body position
Snoring
S
Time Hours Epoch
06:36:26
23:27:27
PLMs
https://t.me/medicina_free
R
W
N1
N2
N3
12 am
0 6
23:27:27
+5 +5 +5 +5 +5 +5 +5 +5
100
pO
2
80
R
B
L
F
U
+5
+10
0 6
1
126
12 am 1 am 2 am 3 am 4 am 5 am 6 am
1
126
Figure 10. PSG report in a person without a sleep disorder (minor snoring with an AHI <5 events·h1), demonstrating normal sleep architecture, sleep progression and sleep cycling. Cn.A: central apnoeas; Ob.A: obstructive apnoeas; Mx.A: mixed apnoeas; Cn.H: central hypopnoeas; Ob.H: obstructive hypopnoeas; Mx.H: mixed hypopnoeas; Uns: unsure; RERA: respiratory eort-related arousals; PLMs: periodic limb movements in sleep.
Figure 10 depicts a summary report page of a normal PSG scored using AASM (2007 and later rules) and figure 11 a PSG depicting severe sleep apnoea.
The PSG is used in the diagnosis or exclusion of SDB, disorders of central hypersomnolence, parasomnias and abnormal movements during sleep. It is also an important sleep research tool and provides information on sleep duration, sleep amount, sleep cycling and amounts of dierent sleep stages and quality of sleep.
When interpreting and reporting the final PSG output summary, the method is usually to first look at and comment on the hypnogram. Of interest are the sleep architecture, sleep stage cycling, percentage of sleep stages (whether low or high), sleep fragmentation, arousal index and periods of wakefulness. Keep in mind the distribution of sleep stages across the lifespan and that various pathological states can alter these. The second stage of interpretation comprises assessment for respiratory abnormalities, ECG and movement traces in addition to abnormalities in oximetry,
128
P
(if performed), body position and relevance of sleep stage to these observations.
tcCO
2
Detailed examination of the raw data should be possible and is important in the case of abnormal behaviours captured on video, such as seizures, parasomnias, etc.
1 am 2 am 3 am 4 am 5 am 6 am
2
246
2
246
3
366
3
366
4
486
4
486
ERS Handbook: Respiratory Sleep Medicine
5
606
5
606
6
726
06:36:26
6
726
7
846
7
846
Methods of dierent sleep tests
23:40:30 06:12:59
Cn.A
RERA
Uns
Mx.H
Ob.H
Cn.H
Mx.A
Ob.A
Apnoea graph
Sleep stage summary
https://t.me/medicina_free
R
W
N1
N2
N3
+5 +5 +5 +5 +5 +5 +5 +5
pO
2
Body position
Snoring
PLMs
Time Hours Epoch
100
70
R
B
L
F
U
+5
+10
12 am 1 am 2 am 3 am 4 am 5 am 6 am
0 6
126
1
246
2
366
3
486
4
606
5
726
6
S
Figure 11. PSG report consistent with severe sleep apnoea. The hypnogram shows a paucity of R-sleep and absence of N3 sleep, poor sleep cycling and sleep fragmentation. There is severe arterial oxygen desaturation associated with repetitive obstructive events. For abbreviations, see figure 10.
Limited channel/type III devices/respiratory polygraphy/home sleep apnoea testing
Because SAHS is such a highly prevalent disorder among adults, less expensive, more portable and more time-ecient methods of measuring the respiratory component of PSG have been developed over the past 30 years.
Known as respiratory polygraphs (RP), polygraphy (PG), type III devices, cardio­respiratory monitors, limited channel studies and home sleep apnoea tests (HSAT), they generally encompass technology developed to measure airflow, respiratory eort, oxygen saturation and heart rate, to the exclusion of EEG. The great advantages of these systems are price, portability and convenience to the patient. Although automated scoring algorithms exist, as with PSG, manual scoring is still recommended.
These abbreviated forms of assessing primarily respiration during sleep generally comprise a minimum of four channels: airflow, respiratory eort, oxygen saturation, and pulse or heart rate. Previously, in this system one signal was one channel and one sensor. In the context of ongoing technical innovations, one sensor will oen convey several signals and represent several channels. One example is the nasal cannula, which records pressure changes. However, derivations from this one sensor allow for calculation of airflow, and if higher frequency vibrations are separated using adequate filtering, then snoring can also be detected and recorded. Thus, one sensor produces two signals and becomes two channels.
With reference to ongoing innovations in signal detection and processing, a new classification system was proposed in 2011 to evaluate the physiological information picked up by sensors. The SCOPER (Sleep, Cardiovascular, Oxygen, Position, Eort, and Respiration) system was developed to reclassify the type I to IV channel counting perspective of sleep recording systems in a more physiologically oriented manner,
129ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
https://t.me/medicina_free
bearing in mind that one sensor might deliver diverse physiological information, allowing for the definition of a reference standard with respect to physiological information (such as EEG/EOG/EMG for sleep) at the top end and a lower accuracy or surrogate measure (such as actigraphy for sleep) at the other end. Although this classification is not evidence-based, it provides a scheme to assess the quality of signals in terms of physiological information (table 7).
In summary, the recommended minimum number of signals to score respiratory events accurately using current AASM criteria include heart rate, oximetry, nasal airflow signals and respiratory eort bands. A position sensor should be used to dierentiate supine from non-supine respiratory event severity. Peripheral arterial tonometry does not measure airflow and may lead to misclassification of OSA at higher and lower rates of SDB; it is likely to be most useful in younger patients with a high pre-test probability of OSA and no significant comorbidities. Overall, the diagnostic accuracy of the degree of OSA severity is significantly lower when using type III devices in an unattended setting. Failure rates can be high, so it is important to keep a record of reasons for failure and information on study quality. As stated earlier, manual scoring is recommended, and a high-quality system should allow for manual editing of automated scoring programs. The recent ERS technical standards for using type III devices (limited channel studies) in the diagnosis of SDB in adults and children (Riha et al., 2023), suggests that when undertaken in an attended setting, the sensitivity and specificity for diagnosing OSA is suciently high with an AHI >10 events·h−1 irrespective of scoring criteria utilised.
Table 7. The SCOPER categorisation system
Sleep Cardiovascular Oximetry
S1: sleep by 3 EEG channels¶ with EOG and chin EMG
S2: sleep by <3 EEG¶ with or without EOG or chin EMG
S3: sleep surrogate, e.g. actigraphy
S4: other sleep measure
RIP: respiratory inductance plethysmography. #: proper oximetry sampling is defined as 3 s averaging and a minimum of 10 Hz sampling rate (25 Hz desirable). ¶: three EEG channels defined as frontal, central and occipital. Reproduced and modified from Collop et al. (2011) with permission.
C1: more than 1 ECG lead – can derive events
C2: peripheral arterial tonometry
C3: standard ECG measure (1 lead)
C4: derived pulse (typically from oximetry)
C5: other cardiac measure
O1: oximetry (finger or ear) with recommended sampling
O1x: oximetry (finger or ear) without recommended sampling (per Scoring Manual) or not described
O2: oximetry with alternative site (e.g. forehead)
O3: other oximetry
#
Position Eort
P1: video or visual position measurement
P2: non-visual position measurement
E1: 2 RIP belts
E2: 1 RIP belt
E3: derived eort (e.g. forehead versus pressure, FVP)
E4: other eort measure (including piezo belts)
130
ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
https://t.me/medicina_free
Additionally, it is important to note that published information on the acceptability, sensitivity and specificity of type III studies in populations other than obese, middle­aged men with symptoms consistent with OSA is limited. User-friendliness (for both clinician and patient) and ease of scoring and setting up the equipment should be a strong consideration when incorporating type III devices in the diagnostic pathway of a sleep centre. This includes assessing the quality of the sensors and scoring soware, disposable and non-disposable consumables, cleaning protocols, patient acceptability and device reliability. If the clinical suspicion of OSA is high, patients should be advised of the risk of having to repeat the study or undertake PSG to make an accurate diagnosis, particularly if the study is unattended.
Regarding terminology used in the reporting of type III studies, the term ‘AHI’ should not, by virtue of the absence of the EEG, be used to describe the summary of breathing events acquired. According to the 2023 ERS technical standards more suitable terms include one of the following:
Apnoeas+hypopnoeas per estimated hours asleep
Respiratory events index (per estimated hours asleep)
Apnoeas+hypopnoeas per estimated hours of monitoring time
For further and more detailed discussion of type III devices used in the screening and diagnosis of SDB, the reader is referred to the 2023 ERS technical standards (Riha et al., 2023).
Type IV studies
Type IV studies generally comprise one to two sensors, one of which will be oximetry and the other will be airflow, pulse rate or tracheal sound. Oximetry as a stand-alone test is also used for screening for SDB (table 8). It is portable, relatively cheap, and minimally obtrusive for patients. The usual indices derived from pulse oximetry undertaken whilst asleep include the oxygen desaturation index (ODI), the cumulative time below a certain saturation level, and minimum and mean saturation values during the monitoring period. The ODI has shown significant complementarity with other cardiorespiratory signals related to OSA, such as pulse rate and respiratory events. Newer measures of hypoxaemia have become more prevalent in the past decade, including hypoxic burden indices (saturation impairment time, desaturation
Table 8. Methods and parameters in conventional interpretation of the oximetry trace in SDB
Method Parameters evaluated Visual inspection Recurrent drops in the S
S
data histogram and
pO
2
simple statistics
Intermittent hypoxaemia ODI: 3% or 4% in adults Persistent hypoxaemia Overnight minimum saturation
Reproduced and modified from Álvarez et al. (2022) with permission.
profile during the night
pO
Saw-tooth pattern Clusters of desaturations Mean (central tendency), variance (dispersion), skewness
(asymmetry), kurtosis (peakedness)
Median (central tendency), quantiles, and interquartile
range (dispersion)
Delta index (variability measure)
Percentage of cumulative time spent with a saturation
below a threshold: 80–90% in adults
2
131ERS Handbook: Respiratory Sleep Medicine
Methods of dierent sleep tests
https://t.me/medicina_free
severity, hypoxia load, and hypoxic burden), which are considered complementary to AHI/ODI and conventional hypoxaemia measures (cumulative time below 90% (CT90) and minimum saturation).
Evidence-based technical specifications for oximetry deployed in the diagnosis and screening of SDB do not exist. However, it is recommended that a minimum sampling rate should be 10 Hz and desirable sampling rate should be 25 Hz with an averaging of three values and the accuracy ±2%. A resolution of 0.1% is desirable, but not specified in the AASM.
The sensitivity and specificity of using oximetry alone in the diagnosis of sleep apnoea has been shown to range from 30–100%, depending on the machine utilised, the population tested, whether the study is attended or unattended, and whether the technique is combined with additional questionnaires or other forms of screening to ascertain pre-test probability of SDB.
As such, it is a single parameter technique which also has no redundancy in the system to capture respiratory and sleep signals should it fail and it is prone to misinterpretation. It should not be relied on as a diagnostic technique in isolation, but may be useful in certain circumstances where there is a high suspicion of sleep apnoea, for monitoring progression of diseases resulting in nocturnal desaturation/hypoventilation, and for monitoring response to therapy in the context of a known diagnosis.
Further reading
Álvarez D, et al. (2022). Oximetry indices in the management of sleep apnea: from overnight
minimum saturation to the novel hypoxemia measures. Adv Exp Med Biol; 1384: 219–239.
American Academy of Sleep Medicine (2014). The International Classification of Sleep Disorders:
Diagnostic and Coding Manual. 3rd Edn. Darien, American Academy of Sleep Medicine.
Collop NA, et al. (2011). Obstructive sleep apnea devices for out-of-center (OOC) testing:
technology evaluation. J Clin Sleep Med; 7: 531–548.
Hampton J, et al. (2019). The ECG Made Easy. 9th Edn. Elsevier Health.
Hirshkowitz M. (2004). Normal human sleep: an overview. Med Clin North Am; 88: 551–565.
Mattice C, et al. (eds) (2020). Fundamentals of Sleep Technology. 3rd Edn. Philadelphia,
Wolters Kluwer Health.
Pretto JJ, et al. (2014). Clinical use of pulse oximetry: ocial guidelines from the Thoracic
Society of Australia and New Zealand. Respirology; 19: 38–46.
Rechtschaen A, et al. (1968). A Manual of Standardised Terminology, Techniques and Scoring
System for Sleep Stages of Human Subjects. Bethesda, National Institutes of Health.
Riha RL (2012). Polysomnography. In: Simonds AK, et al. ERS Handbook of Respiratory Sleep
Medicine. Sheeld, European Respiratory Society; pp. 120–130.
Riha RL, et al. (2023). ERS technical standards for using type III devices (limited channel
studies) in the diagnosis of sleep disordered breathing in adults and children. Eur Respir J; 61:
2200422.
Standards of Practice Committee of the American Sleep Disorders Association (1994). Practice
parameters for the use of portable recording in the assessment of obstructive sleep apnea. Sleep; 17: 372–377.
Troester MM, et al. (2023). The AASM manual for the scoring of sleep and associated events:
rules, terminology and technical specifications: version 3. Darien, American Academy of Sleep Medicine.
132
ERS Handbook: Respiratory Sleep Medicine
Limitations of oximetry
https://t.me/medicina_free
and respiratory polygraphy in comparison with hospital-based PSG studies
Renata L. Riha
PSG undertaken in a hospital-based setting is considered the gold-standard sleep test, largely because all sleep, respiratory and movement parameters are monitored simultaneously, with video, direct observation, and assistance to the patient available throughout the testing period. However, it is expensive and time-consuming and may not always reflect the natural sleep state of the patient. Unfortunately, despite their advantages, the more abbreviated methods of testing for SDB also have several limitations which are discussed below.
Type III devices/respiratory polygraphy
In attended settings, type III devices have a high sensitivity and specificity for diagnosing SDB. In unattended settings, they should be considered as screening tools due to a high number of errors that can emerge when a patient is allowed to independently apply the sensors in their own environment. Accuracy is also determined by the degree of clinical pre-test probability of SDB.
However, irrespective of the setting of the test, the greatest limitation lies in the absence of EEG. Therefore, any scoring of respiratory events using current American Academy of Sleep Medicine (AASM) guidelines cannot incorporate arousals to score hypopnoeas and obstructive events with no, or minimal, oxygen desaturations.
There is no accurate method for reporting sleep, and thus, total recording time is oen used as the denominator to calculate respiratory event frequency or the oxygen desaturation index (ODI). The dierence between the mean total recording time and mean total sleep time ranges between 1 h and 3 h in the literature.
Key points
• In comparison to hospital-based PSG, type III studies lack EEG-defined sleep as a denominator for respiratory events.
• Type III studies that are undertaken in an unattended setting may have high failure rates and should be considered as screening tools only.
• Oximetry with or without one additional channel should be considered as a screening tool only in patients with a high probability of SDB.
• Interpretation of oximetry can never be anything other than an assumption as to the type and cause of SDB.
133ERS Handbook: Respiratory Sleep Medicine